IronSight AI and Fast Iron Partner to Bring AI-Powered Inventory Capture to Caterpillar, Komatsu and Volvo Equipment Dealers 
WCDPQ Plans South American Expansion in 2027, Including 30 New Positions GMG Provides Commercialisation Progress of THERMAL-XR(R)
BRISBANE, AUS, Aug 28, 2023 – (ACN Newswire) – Graphene Manufacturing Group Ltd. (TSXV: GMG)…
Fierce Biotech Names HiFiBiO Therapeutics a “Fierce 15” Biotech Company of 2023
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#biotech–HiFiBiO Therapeutics, a clinical stage global biotech company focusing on improving patient lives…
Valify Announces Executive Appointments
FRISCO, Texas–(BUSINESS WIRE)–Valify, the pioneering cost-management technology platform specializing in the classification and benchmarking of…
Skyline Champion Announces Acquisition of Regional Homes
TROY, Mich.–(BUSINESS WIRE)–Champion Home Builders and Champion Retail Housing, subsidiaries of Skyline Champion Corporation (NYSE:…
Walker & Dunlop Completes $35 Million Sale of Mixed-Use University Property in Chicago, IL
BETHESDA, Md.–(BUSINESS WIRE)–Walker & Dunlop, Inc. announced today that it arranged the sale of The…
Ransomware Attacks: How To Protect Against Them
Ransomware: a word that strikes fear into business owners everywhere. Learn how you can protect…
T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core Elements…
T2 Biosystems Praises CDC’s Actions Aimed at Optimizing U.S. Hospital Sepsis Programs
The U.S. Centers for Disease Control and Prevention Releases 2023 Hospital Sepsis Program Core Elements…
NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Completed the first tranche of a non-brokered private placement offering of units for gross proceeds…
NurExone Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Completed the first tranche of a non-brokered private placement offering of units for gross proceeds…
Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Fierce Biotech Names Cerevance a “Fierce 15” Biotech Company of 2023
BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
Kenny has proven track record of driving growth at companies within the healthcare space and…
Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors
Kenny has proven track record of driving growth at companies within the healthcare space and…
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
MINNEAPOLIS, Aug. 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company…
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
MINNEAPOLIS, Aug. 28, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company…
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy,…
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
Results from the ORION-8 open-label extension trial show twice-yearly* Leqvio, in addition to statin therapy,…
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
ContraFect to Present at the World Anti-Microbial Resistance Congress 2023
YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…